EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dihydromyricetin attenuates cholestatic liver injury by suppressing JAK2/STAT3-associated NF-κB inflammatory and apoptotic signaling

Yongkang Cheng, Sansan Feng, Yahui Feng, Chunfeng Yang, Chuqiao Sheng, Yumei Li

International Immunopharmacology · 2026-10 · 186 · 117129

DOI: 10.1016/j.intimp.2026.117129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Yongkang Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Intensive Care Unit, Children's Medical Center, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Flavonols, Cholestasis, Anti-Inflammatory Agents. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorFlavonolsCholestasisAnti-Inflammatory AgentsAnimalsJanus Kinase 2ApoptosisNF-kappa BSignal TransductionHumansMiceMale1-NaphthylisothiocyanateMice, Inbred C57BLLiverTaurocholic Acid

Stichwörter der Autor:innen

ApoptosisCholestatic liver injuryDihydromyricetinInflammationJAK2/STAT3NF-κBNetwork pharmacology

Substanzen

Janus Kinase 2STAT3 Transcription FactordihydromyricetinNF-kappa BFlavonolsStat3 protein, mouseAnti-Inflammatory AgentsJak2 protein, mouse1-NaphthylisothiocyanateTaurocholic Acid

Autor:innen und Institutionen

  • Department of Pediatric Intensive Care Unit, Children's Medical Center, The First Hospital of Jilin University, Changchun, China.
  • Department of Developmental and Behavioral Pediatrics, Children's Medical Center, The First Hospital of Jilin University, Changchun, China.
  • Department of Pediatric Intensive Care Unit, Children's Medical Center, The First Hospital of Jilin University, Changchun, China. Electronic address: ym_li@jlu.edu.cn.

Zitieren

APA

Cheng, Y., Feng, S., Feng, Y., Yang, C., Sheng, C., & Li, Y. (2026). Dihydromyricetin attenuates cholestatic liver injury by suppressing JAK2/STAT3-associated NF-κB inflammatory and apoptotic signaling. International Immunopharmacology, 186, 117129. https://doi.org/10.1016/j.intimp.2026.117129

Vancouver

Cheng Y, Feng S, Feng Y, Yang C, Sheng C, Li Y. Dihydromyricetin attenuates cholestatic liver injury by suppressing JAK2/STAT3-associated NF-κB inflammatory and apoptotic signaling. International Immunopharmacology. 2026;186:117129. doi:10.1016/j.intimp.2026.117129

BibTeX
@article{Cheng2026,
  author = {Cheng, Yongkang and Feng, Sansan and Feng, Yahui and Yang, Chunfeng and Sheng, Chuqiao and Li, Yumei},
  title = {Dihydromyricetin attenuates cholestatic liver injury by suppressing JAK2/STAT3-associated NF-κB inflammatory and apoptotic signaling},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {186},
  pages = {117129},
  doi = {10.1016/j.intimp.2026.117129}
}
Kostenlos starten →